1. Home
  2. RGEN vs LAD Comparison

RGEN vs LAD Comparison

Compare RGEN & LAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • LAD
  • Stock Information
  • Founded
  • RGEN 1981
  • LAD 1946
  • Country
  • RGEN United States
  • LAD United States
  • Employees
  • RGEN N/A
  • LAD N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • LAD Retail-Auto Dealers and Gas Stations
  • Sector
  • RGEN Health Care
  • LAD Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • LAD Nasdaq
  • Market Cap
  • RGEN 8.0B
  • LAD 7.6B
  • IPO Year
  • RGEN N/A
  • LAD 1996
  • Fundamental
  • Price
  • RGEN $131.55
  • LAD $326.23
  • Analyst Decision
  • RGEN Buy
  • LAD Strong Buy
  • Analyst Count
  • RGEN 12
  • LAD 13
  • Target Price
  • RGEN $172.67
  • LAD $375.15
  • AVG Volume (30 Days)
  • RGEN 847.4K
  • LAD 336.6K
  • Earning Date
  • RGEN 04-29-2025
  • LAD 04-23-2025
  • Dividend Yield
  • RGEN N/A
  • LAD 0.67%
  • EPS Growth
  • RGEN N/A
  • LAD N/A
  • EPS
  • RGEN N/A
  • LAD 31.74
  • Revenue
  • RGEN $650,429,000.00
  • LAD $36,804,700,000.00
  • Revenue This Year
  • RGEN $13.93
  • LAD $8.04
  • Revenue Next Year
  • RGEN $14.35
  • LAD $7.36
  • P/E Ratio
  • RGEN N/A
  • LAD $10.27
  • Revenue Growth
  • RGEN 4.88
  • LAD 12.81
  • 52 Week Low
  • RGEN $102.97
  • LAD $243.04
  • 52 Week High
  • RGEN $182.52
  • LAD $405.68
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 47.85
  • LAD 65.70
  • Support Level
  • RGEN $123.10
  • LAD $292.97
  • Resistance Level
  • RGEN $143.56
  • LAD $329.26
  • Average True Range (ATR)
  • RGEN 6.82
  • LAD 8.35
  • MACD
  • RGEN -0.65
  • LAD 4.09
  • Stochastic Oscillator
  • RGEN 33.43
  • LAD 86.22

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About LAD Lithia Motors Inc.

Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.

Share on Social Networks: